Barecetamab (Anti-ERBB3 / HER3) | EGFR antibody | Read Reviews & Product Use Citations

Barecetamab (Anti-ERBB3/HER3) is a fully human antibody directed against the receptor tyrosine-protein kinase erbB-3 (ErbB3; HER3) with antineoplastic activity. It has the potential to be used in research on recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). MW: 137.96 KD.

Purity & Quality Control

Batch: A290101 Purity: 99% Protein concentration: 4.62mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective EGFR Inhibitors

Biological Activity

Description	Barecetamab (Anti-ERBB3/HER3) is a fully human antibody directed against the receptor tyrosine-protein kinase erbB-3 (ErbB3; HER3) with antineoplastic activity. It has the potential to be used in research on recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). MW: 137.96 KD.

References
[1] Seo S, et al. Int J Cancer. 2023;153(8):1501-1511.

References

[1] Seo S, et al. Int J Cancer. 2023;153(8):1501-1511.

Product Details

CAS No.	2275727-74-5
Molecular Weight	137.96
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field